| Popis: |
The study investigated changes in gut microbiota composition in patients with acute coronary syndrome (ACS) before and after treatment. The study identified specific bacteria, genes, and metabolic pathways that may be associated with cardiovascular disease risk and found that the gut microbiota of patients returned to a relatively stable state one month after treatment. This study may provide insights into the underlying mechanisms of ACS and to identify potential therapeutic targets. Specifically, the identification of specific bacteria, genes, and metabolic pathways that may be associated with cardiovascular disease risk could lead to the development of targeted interventions and treatments for ACS. |
